Compare
Amtd Idea Group vs Core Scientific, Inc./tx vs Hyperliquid Strategies Inc vs Chime Financial, Inc.
| Latest fiscal year | Amtd Idea Group AMTDRevenue covers only part of its income (partial revenue) | Core Scientific, Inc./tx CORZ | Hyperliquid Strategies Inc PURRRevenue covers only part of its income (partial revenue) | Chime Financial, Inc. CHYM |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-06-30 | 2025-12-31 |
| Revenue | n/a | $319.02M | n/a | $2.19B |
| Revenue growth (YoY) | n/a | -37.5% | n/a | +30.7% |
| Gross margin | n/a | 11.9% | n/a | 88.0% |
| Operating margin | n/a | -77.0% | n/a | -47.6% |
| Net margin | n/a | -90.5% | n/a | -46.2% |
| Net income | $67.25M | -$288.62M | $305.54M | -$1.01B |
| EPS (Diluted) | n/a | -$0.88 | $3.21 | -$4.27 |
| Operating cash flow | $17.84M | $278.25M | -$19.15M | $52.78M |
| Free cash flow | $17.09M | -$450.75M | n/a | $32.89M |
| Cash & equivalents | $51.07M | $311.38M | $137.92M | $466.25M |
| Total assets | $2.30B | $2.35B | $2.06B | $1.96B |
| Total liabilities | $385.38M | $3.31B | $187.14M | $562.90M |
| Shareholders' equity | $1.38B | -$962.74M | $1.87B | $1.40B |
| Return on year-end equity | 4.9% | n/a | 16.3% | -72.1% |
| Shares outstanding | n/a | 314.23M | 200.55M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Amtd Idea Group | Core Scientific, Inc./tx | Hyperliquid Strategies Inc | Chime Financial, Inc. |
|---|---|---|---|---|
| Latest | n/a | $319.02M Ended 2025-12-31 | n/a | $2.19B Ended 2025-12-31 |
| 1 year earlier | n/a | $510.67M Ended 2024-12-31 | n/a | $1.67B Ended 2024-12-31 |
| 2 years earlier | n/a | $502.40M Ended 2023-12-31 | n/a | $1.28B Ended 2023-12-31 |
| 3 years earlier | n/a | $640.31M Ended 2022-12-31 | n/a | n/a |
| 4 years earlier | n/a | $544.48M Ended 2021-12-31 | n/a | n/a |